Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells

Molecular and Cellular Biology

Volumn 19, Issue 8, 1999, Pages 5326-5338

  Kim, Hongkyun ^a   Baumann, Heinz ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; GLYCOPROTEIN GP 130; INTERLEUKIN 6 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE PHOSPHATASE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE MUTATION; GENE OVEREXPRESSION; IMMEDIATE EARLY GENE; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA; JANUS;

EID: 0032788884     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.8.5326     Document Type: Article

References (85)

1. Adachi, M., M. Ishino, T. Torigoe, Y. Minami, T. Matozaki, T. Miyazaki, T. Taniguchi, Y. Hinoda, and K. Imai. 1997. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain. Oncogene 14: 1629-1633.
2. Auble, D. T., and C. E. Brinckerhoff. 1991. The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry 30:4629-4635.
3. Baumann, H., R. E. Hill, D. N. Sander, and G. P. Jahreis. 1986. Regulation of major acute-phase plasma proteins by hepatocyte-stimulating factors of human squamous carcinoma cells. J. Cell Biol. 102:370-383.
4. Baumann, H., K. R. Prowse, S. Marinokovic, K.-A. Won, and G. P. Jahreis. 1989. Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann. N. Y. Acad. Sci. 557:280-295.
5. Baumann, H., D. Gearing, and S. F. Ziegler. 1994. Signaling by the cytoplasmic domain of hematopoietin receptors involves two distinguishable mechanisms in hepatic cells. J. Biol. Chem. 269:16297-16304.
6. Bellido, T., C. A. O'Brien, P. K. Roberson, and S. C. Manolagas. 1998. Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. J. Biol. Chem. 273:21137-21144.
7. Botelho, F. M., D. R. Edwards, and C. D. Richards. 1998. Oncostatin M stimulates c-Fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter. J. Biol. Chem. 273: 5211-5218.
8. Bromberg, J. F., C. M. Horvath, D. Besser, W. W. Lathem, and J. E. Darnell, Jr. 1998. Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18:2553-2558.
9. Bugno, M., L. Graeve, P. Gatsios, A. Koj, P. C. Heinrich, J. Travis, and T. Kordula. 1995. Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. Nucleic Acids Res. 23:5041-5047.
10. Campos, S. P., Y. Wang, and H. Baumann. 1996. Insulin modulates STAT3 protein activation and gene transcription in hepatic cells. J. Biol. Chem. 271:24418-24424.
11. Cha, H. H., E. J. Cram, E. C. Wang, A. J. Huang, H. G. Kasler, and G. L. Firestone. 1998. Glucocorticoids stimulate p21 gene expression by targeting multiple transcriptional elements within a steroid responsive region of the p21waf1/cip1 promoter in rat hepatoma cells. J. Biol. Chem. 273:1998-2007.
12. Chirgwin, J. M., A. E. Przybyia, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
13. David, M., G. Zhou, R. Pine, J. E. Dixon, and A. C. Larner. 1996. The SH2 domain-containing tyrosine phosphatase PTP1D is required for interferon alpha/beta-induced gene expression. J. Biol. Chem. 271:15862-15865.
14. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686-7689.
15. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, T. Miyazaki, N. Leonor, T. Taniguchi, T. Fujita, Y. Kanakura, S. Komiya, and A. Yoshimura, 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-924.
16. Feng, G.-S., C.-C. Hui, and T. Pawson. 1993. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science 259:1607-1611.
17. Fuhrer, D. K., G. S. Feng, and Y. C. Yang. 1995. Syp associates with gp130 and Janus kinase 2 in response to interleukin-11 in 3T3-L1 mouse preadipocytes. J. Biol. Chem. 270:24826-24830.
18. Fujioka, Y., T. Matozaki, T. Noguchi, A. Iwamalsu, T. Yamao, N. Takahashi, M. Tsuda, T. Takada, and M. Kasuga. 1996. A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion. Mol. Cell. Biol. 16:6887-6899.
19. Fukada, T., M. Hibi, Y. Yamanaka, M. Takahashi-Tezuka, Y. Fujitani, T. Yamaguchi, K. Nakajima, and T. Hirano. 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 5:449-460.
20. Gutch, M. J., A. J. Flint, J. Keller, N. K. Tonks, and M. O. Hengartner. 1998. The Caenorhabditis elegans SH2 domain-containing protein tyrosine phosphatase PTP-2 participates in signal transduction during oogenesis and vulval development. Genes Dev. 12:571-585.
21. Hattori, M., A. Tugores, J. K. Westwick, L. Veloz, H. L. Leffert, M. Karin, and D. A. Brenner. 1993. Activation of activating protein 1 during hepatic acute phase response. Am. J. Physiol. 264:G95-G103.
22. Hawley, R. G., F. H. Lieu, A. Z. Fong, S. J. Goldman, J. P. Leonard, and T. S. Hawley. 1996. Retroviral vectors for production of interleukin-12 in the bone marrow to induce a graft-versus-leukemia effect. Ann. N.Y., Acad. Sci. 795: 341-345.
23. Hemmann, U., C. Gerhartz, B. Heesel, J. Sasse, G. Kurapkat, J. Grotzinger, A. Wollmer, Z. Zhong, J. E. Darnell, Jr., L. Graeve, P. C. Heinrich, and F. Horn. 1996. Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. J. Biol. Chem. 271:12999-3007.
24. Herbst, R., P. M. Carroll, J. D. Allard, J. Schilling, T. Raabe, and M. A. Simon. 1996. Daughter of sevenless is a substrate of the phosphotyrosine phosphatase Corkscrew and functions during sevenless signaling. Cell 85: 899-909.
25. Hirano, T., K. Nakajima, and M. Hibi. 1997. Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 8:241-252.
26. Hof, P., S. Pluskey, S. Dhe-Paganon, M. J. Eck, and S. E. Shoelson. 1998. Crystal structure of the tyrosine phosphatase SHP-2. Cell 92:441-450.
27. Horan, T., J. Wen, L. Narhi, V. Parker, A. Garcia, T. Arakawa, and J. Philo. 1996. Dimerization of the extracellular domain of granulocyte-colony stimulating factor receptor by ligand binding: a monovalent ligand induces 2:2 complexes. Biochemistry 35:4886-4896.
28. Jiao, H., K. Berrada, W. Yang, M. Tabrizi, L. C. Platanias, and T. Yi. 1996 Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol. Cell. Biol. 16:6985-6992.
29. Kaptein, A., V. Paillard, and M. Saunders. 1996. Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J. Biol. Chem. 271:5961-5964.
30. Kazlauskas, A., G. S. Feng, T. Pawson, and M. Valius. 1993. The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp. Proc. Natl. Acad. Sci. USA 90:6939-6943.
31. Kharitonenkov, A., Z. Chen, I. Sures, H. Wang, J. Schilling, and A. Ullrich. 1997. A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature 386:181-186.
32. Kharitonenkov, A., J. Schnekenburger, Z. Chen, P. Knyazev, S. Ali, E. Zwick, M. White, and A. Ullrich. 1995. Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction. J. Biol. Chem. 270:29189-29193.
33. Kim, H., and H. Baumann. 1997. The carboxyl-terminal region of STAT3 controls gene induction by the mouse haptoglobin promoter. J. Biol. Chem. 272:14571-14579.
34. Kim, H., and H. Baumann. Unpublished observation.
35. Kim, H., T. S. Hawley, R. G. Hawley, and H. Baumann. 1998. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells. Mol. Cell. Biol. 18:1525-1533.
36. Klingmuller, U., U. Lorenz, L. C. Cantley, B. G. Neel, and H. F. Lodish. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80:729-738.
37. Knowles, B. B., C. C. Howe, and D. P. Aden. 1980. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209:497-499.
38. Kordula, T., J. Ripperger, K. M. Morella, J. Travis, and H. Baumann. 1996. Two separate signal transducer and activator of transcription proteins regulate transcription of the serine proteinase inhibitor-3 gene in hepatic cells. J. Biol. Chem. 271:6752-6757.
39. Kurzus, E., H. Nagase, R. Rydell, and J. Travis. 1997. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J. Biol. Chem. 272:1188-1196.
40. Krstic, M. D., I. Rogatsky, K. R. Yamamoto, and M. J. Garabedian. 1997. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17:3947-3954.
41. Kuhne, M. R., T. Pawson, G. E. Lienhard, and G.-S. Feng. 1993. The insulin receptor substrate 1 associates with the SH-2 containing phosphotyrosine phosphatase Syp. J. Biol. Chem. 268:11479-11481.
42. Kumar, G., S. Gupta, S. Wang, and A. E. Nel. 1994. Involvement of Janus kinases, p52shc, Raf-1, and MEK-1 in the IL-6 induced mitogen-activated protein kinase cascade of growth responsive B cell line. J. Immunol. 152: 4436-4447.
43. Lai, C. F., J. Ripperger, K. K. Morella, Y. Wang, D. P. Gearing, G. H. Fey, and H. Baumann. 1995. Separate signaling mechanisms are involved in the control of STAT protein activation and gene regulation via the interleukin 6 response element by the box 3 motif of gp130. J. Biol. Chem. 270:14847-14850.
44. Lai, C.-F., J. Ripperger, Y. Wang, H. Kim, R. B. Hawley, and H. Baumann. 1999. The STAT3-independent signaling pathway by glycoprotein 130 in hepatic cells. J. Biol. Chem., 274:7793-7802.
45. Leffert, H. L., K. S. Koch, X. P. Lu, D. A. Brenner, M. Karin, H. F. Skelly, R. A. Rippe, G. Fey, and M. Chojkier. 1990. Cellular and molecular biology of hepatocyte growth, regeneration and gene expression. Adv. Second Messenger Phosphoprotein Res. 24:352-358.
46. Li, W., R. Nishimura, A. Kashishian, A. G. Batzer, W. J. Kim, J. A. Cooper, and J. Schlessinger. 1994. A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase. Mol. Cell. Biol. 14: 509-517.
47. Lutticken, C., U. M. Wegenka, J. Yuan, J. Buschmann, C. Schindler, A. Ziemiecki, A. G. Harpur, A. F. Wilks, K. Yasukawa, T. Taga, T. Kishimoto, G. Barbieri, S. Pellegrini, M. Sendtner, P. Cotteinrich, and F. Horn. 1994. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 263:89-92.
48. Milarski, K. L., and A. R. Saltiel. 1994. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J. Biol. Chem. 269:21239-21243.
49. Milland, J., A. Tsykin, T. Thomas, A. R. Aldred, T. Cole, and G. Schreiber. 1990. Gene expression in regenerating and acute-phase rat liver. Am. J. Physiol. 259:G340-G347.
50. Minami, M., M. Inoue, S. Wei, K. Takeda, M. Matsumoto, T. Kishimoto, and S. Akira. 1996. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. USA 93:3963-3966.
51. Mosley, B., M. P. Beckmann, C. J. March, R. L. Idzerda, S. D. Gimpel, T. Vanden Bos, D. Friend, A. Alpert, D. Anderson, J. Jackson, J. M. Wignall, C. Smith, B. Gallis, J. E. Sims, D. Urdal, M. B. Widmer, and D. Cosman. 1989. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59:335-348.
52. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, S. Akira, and T. Kishimoto. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924-929.
53. Nakajima, T., S. Kinoshita, T. Sasagawa, K. Sasaki, M. Naruto, T. Kishimoto, and S. Akira. 1993. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA 90:2207-2211.
54. Neel, B. G., and N. K. Tonks. 1997. Protein tyrosine phosphatases in signal transduction. Curr. Opin. Cell Biol. 9:193-204.
55. Ohnishi, H., M. Kubota, A. Ohtake, K. Sato, and S. Sano. 1996. Activation of protein-tyrosine phosphatase SH-PTP2 by a tyrosine-based activation motif of a novel brain molecule. J. Biol. Chem. 271:25569-25574.
56. Qiu, Y., L. Ravi, and H. J. Kung. 1998. Requirement of ErbB2 for signaling by interleukin-6 in prostate carcinoma cells. Nature 393:83-85.
57. Qu, C. K., and G. S. Feng. 1998. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation. Oncogene 17:433-439.
58. Ripperger, J. A., S. Fritz, K. Richter, G. M. Hocke, F. Lottspeich, and G. H. Fey. 1995. Transcription factors Stat3 and Stat5b are present in rat liver nuclei late in an acute phase response and bind interleukin-6 response elements. J. Biol. Chem. 270:29998-30006.
59. Sagawa, K., T. Kimura, M. Swieter, and R. P. Siraganian. 1997. The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1 (CD31). J. Biol. Chem. 272:31086-31091.
60. Saxton, T. M., M. Henkemeyer, S. Gasca, R. Shen, D. J. Rossi, F. Shalaby, G. S. Feng, and T. Pawson. 1997. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 16:2352-2364.
61. Schiemann, W. P., J. L. Bartoe, and N. M. Nathanson. 1997. Box 3-independent signaling mechanisms are involved in leukemia inhibitory factor receptor alpha- and gp130-mediated stimulation of mitogen-activated protein kinase. J. Biol. Chem. 272:16631-16636.
62. Scotte, M., S. Masson, S. Lyoumi, M. Hiron, P. Teniere, J. P. Lebreton, and M. Daveau. 1997. Cytokine gene expression in liver following minor or major hepatectomy in rat. Cytokine 9:859-867.
63. Servidei, T., Y. Aoki, S. E. Lewis, A. Symes, J. S. Fink, and S. A. Reeves. 1998. Coordinate regulation of STAT signaling and c-fos expression by the tyrosine phosphatase SHP-2. J. Biol. Chem. 273:6233-6241.
64. Stahl, N., T. G. Boulton, T. Farruggella, N. Y. Ip, S. Davis, B. A. Witthuhn, F. W. Quelle, O. Silvennoinen, G. Barbieri, S. Pellegrini, J. N. Ihle, and G. D. Yancopoulos. 1994. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263:92-95.
65. Stahl, N., T. J. Farruggella, T. G. Boulton, Z. Zhong, J. E. Darnell, Jr., and G. D. Yancopoulos. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267:1349-1353.
66. Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921.
67. Symes, A., N. Stahl, S. A. Reeves, T. Farruggella, T. Servidei, T. Gearan, G. Yancopoulos, and J. S. Fink. 1997. The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression. Curr. Biol. 7:697-700.
68. Takada, T., T. Matozaki, H. Takeda, K. Fukunaga, T. Noguchi, Y. Fujioka. I. Okazaki, M. Tsuda, T. Yamao, F. Ochi, and M. Kasuga. 1998. Roles of the complex formation of SHPS-1 with SHP-2 in insulin-stimulated mitogen-activated protein kinase activation. J. Biol. Chem. 273:9234-9242.
69. Tang, T. L., R. M. Freeman, Jr., A. M. O'Reilly, B. G. Neel, and S. Y. Sokol. 1995. The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development. Cell 80: 473-483.
70. Tomic, S., U. Greiser, R. Lammers, A. Kharitonenkov, E. Imyanitov, A. Ulrich, and F. D. Bohmer. 1995. Association of SH2 domain protein tyrosine phosphatase with the epidermal growth factor receptor in human tumor cells. J. Biol. Chem. 270:21277-21284.
71. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
72. Treisman, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:205-215.
73. Ugi, S., H. Maegawa, A. Kashiwagi, M. Adachi, J. M. Olefsky, and R. Kikkawa. 1996. Expression of dominant negative mutant SHPTP2 attenuates phosphatidylinositol 3′-kinase activity via modulation of phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 271:12595-12602.
74. Wang, Y., and G. M. Fuller. 1995. Interleukin-6 and ciliary neurotrophic factor trigger Janus kinase activation and early gene response in rat hepatocytes. Gene 162:258-289.
75. Wang, Y., J. Ripperger, G. H. Fey, D. Samols, T. Kordula, M. Wetzler, R. A. Van Etten, and H. Baumann. Regulation of hepatic acute phase genes by epidermal growth factor and Src protein tyrosine kinases. Submitted for publication.
76. Wang, Y., K. K. Morella, J. Ripperger, C. F. Lai, D. P. Gearing, G. H. Fey, S. P. Campos, and H. Baumann. 1995. Receptors for interleukin-3 (IL-3) and growth hormone mediate an IL-6-type transcriptional induction in the presence of JAK2 or STAT3. Blood 86:1671-1679.
77. Wang, Y., C. Zhu, and H. Baumann. Unpublished results.
78. Ward, L. D., A. Hammacher, G. J. Hewlett, J. M. Matthews, L. Fabri, R. L. Moritz, E. C. Nice, J. Weinstock, and R. J. Simpson. 1996. Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex. J. Biol. Chem. 271:20138-20144.
79. Welham, M. J., U. Dechert, K. B. Leslie, F. Jirik, and J. W. Schrader. 1994. Interleukin (IL)-3 and granulocyte/macrophage colony-stimulating factor, but not IL-4, induce tyrosine phosphorylation, activation, and association of SHPTP2 with Grb2 and phosphatidylinositol 3′-kinase. J. Biol. Chem. 269: 23764-23768.
80. Wen, Z. Z. Zhong, and J. E. Darnell, Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-250.
81. Xia, S., D. W. Rose, T. Sasuoka, H. Maegawa, T. R. Burke, P. P. Roller, S. E. Shoelson, and J. M. Olefsky. 1994. SYP(SH-PTP2) is a positive mediator of growth factor-stimulated signal transduction. J. Biol. Chem. 269:21244-21248.
82. Yamanaka, Y., K. Nakajima, T. Fukada, M. Hibi, and T. Hirano. 1996 Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J. 15:1557-1565.
83. Yin, T., R. Shen, G.-S. Feng, and Y.-C. Yang. 1997. Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases. J. Biol. Chem. 272:1032-1037.
84. Zhang, D., M. Sun, D. Samols, and I. Kushner. 1996. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J. Biol. Chem. 271:9503-9509.
85. Zhang, X., J. Blenis, H. C. Li, C. Schindler, and S. Chen-Kiang. 1995 Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267:1990-1994.